Advertisement
Screener

ENLIVEN THERAPEUTICS, INC. (ELVN) Form D

ENLIVEN THERAPEUTICS, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2024-04-03: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2024-03-21; Total offering amount $90,001,086.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2024-04-03Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2024-03-21$90,001,086$90,001,086$020

Similar stocks

Stock NameCountryMarket CapPE Ratio
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
PRECIGEN, INC. (PGEN)United States$2.757B-12.94
AbCellera Biologics Inc. (ABCL)$3.879B-14.59